@article{7c747111499848fcba3170dda5603e64,
title = "Age Does Matter in Adolescents and Young Adults versus Older Adults with Advanced Melanoma: A National Cohort Study Comparing Tumor Characteristics, Treatment Pattern, Toxicity and Response",
keywords = "adolescents, advanced melanoma, aya, braf mutation, checkpoint inhibitors, choice chemotherapy, clinical audit, ipilimumab, metastatic melanoma, microbiome, mutations, nivolumab, open-label, outcome research, pembrolizumab, prospective nation-wide data, risk, survival, targeted therapy, young adults, SURVIVAL, CHOICE CHEMOTHERAPY, MICROBIOME, AYA, BRAF mutation, METASTATIC MELANOMA, MUTATIONS, NIVOLUMAB, RISK, OPEN-LABEL, PEMBROLIZUMAB, IPILIMUMAB",
author = "{van der Kooij}, M.K. and M.J.A.L. Wetzels and M.J.B. Aarts and {van den Berkmortel}, F.W.P.J. and C.U. Blank and M.J. Boers-Sonderen and M.P. Dierselhuis and {de Groot}, J.W.B. and G.A.P. Hospers and D. Piersma and {van Rijn}, R.S. and K.P.M. Suijkerbuijk and {ten Tije}, A.J. and {van der Veldt}, A.A.M. and G. Vreugdenhil and M.W.J.M. Wouters and J.B.A.G. Haanen and {van den Eertwegh}, A.J.M. and E. Bastiaannet and E. Kapiteijn",
year = "2020",
month = aug,
day = "1",
doi = "10.3390/cancers12082072",
language = "English",
volume = "12",
journal = "Cancers",
issn = "2072-6694",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "8",
}